4Danesh. J, Collins. R, PetoR. Chronic infection and coronary heart disease is there a link [ J ]. Lancet, 1997,350:430-436.
5Elizalde J I, Perez pujol S, Heras M, et al. Eeffects of hcli- cobacter pylorieradication and disease recurrence inpa- tients with acute coronary syndromes [ J ]. Helicobacter, 2004,9(6) :681-689.
6Rodeghiero F, Stasi R, Gerasheimer T, et al. Standardization of terminology ,definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from all international working group [J]. Blood,2009,113(11) : 2386-2393.
7Cines DB,Mcmillan R. Pathogenesis of chronic immune thrombocytopenic purpura[ J]. Curr Opin Hematol,2007,14(5) :511-514.
8Guo C,Chu X,Shi Y,et al. Correction of Thl dominant cyto-kine profiles by high-dose dexamethasone in patients with chronic idiopathic thrombocytopenic purpara [ J ]. Clin Immunol, 2007, 42 (27 ) : 557-562.
9Kedama M,Kitadai Y,Ito M,et al. Immune response to CagA protein is associated with improved platelet count after hclicobacter pylori e-radication in patients with idiopathic thrombocytopenic purpura[ J]. Helicobacter,2007,12(1) :3642.
10Oshima T, Ozono R, Yano Y, et al. Association of Helicobacter pylori infection with systemic imflammation and endothelial dysfunction in healthy male subjects[J].Am Coil Cardiol, 2005, 45(8): 1219-1222.
